Literature DB >> 19364822

Coactivator function defines the active estrogen receptor alpha cistrome.

Mathieu Lupien1, Jérôme Eeckhoute, Clifford A Meyer, Susan A Krum, Daniel R Rhodes, X Shirley Liu, Myles Brown.   

Abstract

Proper activation of transcriptional networks in complex organisms is central to the response to stimuli. We demonstrate that the selective activation of a subset of the estrogen receptor alpha (ERalpha) cistrome in MCF7 breast cancer cells provides specificity to the estradiol (E2) response. ERalpha-specific enhancers that are subject to E2-induced coactivator-associated arginine methyltransferase 1 (CARM1) action are critical to E2-stimulated gene expression. This is true for both FoxA1-dependent and independent enhancers. In contrast, a subset of E2-suppressed genes are controlled by FoxA1-independent ERalpha binding sites. Nonetheless, these are sites of E2-induced CARM1 activity. In addition, the MCF7 RNA polymerase II cistrome reveals preferential occupancy of E2-regulated promoters prior to stimulation. Interestingly, E2-suppressed genes tend to lie in otherwise silent genomic regions. Together, our results suggest that the transcriptional response to E2 in breast cancer cells is dependent on the interplay between polymerase II pre-occupied promoters and the subset of the ERalpha cistrome associated with coactivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19364822      PMCID: PMC2698732          DOI: 10.1128/MCB.00020-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

1.  Genome-wide analyses reveal RNA polymerase II located upstream of genes poised for rapid response upon S. cerevisiae stationary phase exit.

Authors:  Marijana Radonjic; Jean-Christophe Andrau; Philip Lijnzaad; Patrick Kemmeren; Thessa T J P Kockelkorn; Dik van Leenen; Nynke L van Berkum; Frank C P Holstege
Journal:  Mol Cell       Date:  2005-04-15       Impact factor: 17.970

2.  Postrecruitment regulation of RNA polymerase II directs rapid signaling responses at the promoters of estrogen target genes.

Authors:  Miltiadis Kininis; Gary D Isaacs; Leighton J Core; Nasun Hah; W Lee Kraus
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

3.  Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers.

Authors:  Jérôme Eeckhoute; Mathieu Lupien; Clifford A Meyer; Michael P Verzi; Ramesh A Shivdasani; X Shirley Liu; Myles Brown
Journal:  Genome Res       Date:  2009-01-07       Impact factor: 9.043

4.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

Authors:  Yixin Wang; Jan G M Klijn; Yi Zhang; Anieta M Sieuwerts; Maxime P Look; Fei Yang; Dmitri Talantov; Mieke Timmermans; Marion E Meijer-van Gelder; Jack Yu; Tim Jatkoe; Els M J J Berns; David Atkins; John A Foekens
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

5.  Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Authors:  Jason S Carroll; X Shirley Liu; Alexander S Brodsky; Wei Li; Clifford A Meyer; Anna J Szary; Jerome Eeckhoute; Wenlin Shao; Eli V Hestermann; Timothy R Geistlinger; Edward A Fox; Pamela A Silver; Myles Brown
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

6.  Interchromosomal associations between alternatively expressed loci.

Authors:  Charalampos G Spilianakis; Maria D Lalioti; Terrence Town; Gap Ryol Lee; Richard A Flavell
Journal:  Nature       Date:  2005-05-08       Impact factor: 49.962

7.  Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation.

Authors:  Marilyn G Pray-Grant; Jeremy A Daniel; David Schieltz; John R Yates; Patrick A Grant
Journal:  Nature       Date:  2005-01-12       Impact factor: 49.962

8.  Breast cancer classification and prognosis based on gene expression profiles from a population-based study.

Authors:  Christos Sotiriou; Soek-Ying Neo; Lisa M McShane; Edward L Korn; Philip M Long; Amir Jazaeri; Philippe Martiat; Steve B Fox; Adrian L Harris; Edison T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

9.  Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice.

Authors:  Neelu Yadav; Jaeho Lee; Jeesun Kim; Jianjun Shen; Mickey C-T Hu; C Marcelo Aldaz; Mark T Bedford
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

10.  The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles.

Authors:  Heather E Cunliffe; Markus Ringnér; Sven Bilke; Robert L Walker; Jennifer M Cheung; Yidong Chen; Paul S Meltzer
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

View more
  43 in total

1.  Transcriptomine, a web resource for nuclear receptor signaling transcriptomes.

Authors:  Scott A Ochsner; Christopher M Watkins; Apollo McOwiti; Xueping Xu; Yolanda F Darlington; Michael D Dehart; Austin J Cooney; David L Steffen; Lauren B Becnel; Neil J McKenna
Journal:  Physiol Genomics       Date:  2012-07-10       Impact factor: 3.107

2.  Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cells.

Authors:  Michael W Bronson; Sara Hillenmeyer; Richard W Park; Alexander S Brodsky
Journal:  Mol Endocrinol       Date:  2010-04-14

Review 3.  Histone arginine methylation.

Authors:  Alessandra Di Lorenzo; Mark T Bedford
Journal:  FEBS Lett       Date:  2010-11-11       Impact factor: 4.124

4.  TDRD3 is an effector molecule for arginine-methylated histone marks.

Authors:  Yanzhong Yang; Yue Lu; Alexsandra Espejo; Jiacai Wu; Wei Xu; Shoudan Liang; Mark T Bedford
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

5.  Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone.

Authors:  Mark B Meyer; Paul D Goetsch; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-18       Impact factor: 4.292

6.  CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.

Authors:  Mariam Al-Dhaheri; Jiacai Wu; Georgios P Skliris; Jun Li; Ken Higashimato; Yidan Wang; Kevin P White; Paul Lambert; Yuerong Zhu; Leigh Murphy; Wei Xu
Journal:  Cancer Res       Date:  2011-01-31       Impact factor: 12.701

Review 7.  Minireview: Conversing with chromatin: the language of nuclear receptors.

Authors:  Simon C Biddie; Sam John
Journal:  Mol Endocrinol       Date:  2013-01-01

8.  AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription.

Authors:  Si Kee Tan; Zhen Hua Lin; Cheng Wei Chang; Vipin Varang; Kern Rei Chng; You Fu Pan; Eu Leong Yong; Wing Kin Sung; Win King Sung; Edwin Cheung
Journal:  EMBO J       Date:  2011-05-13       Impact factor: 11.598

9.  Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells.

Authors:  Charles G Danko; Nasun Hah; Xin Luo; André L Martins; Leighton Core; John T Lis; Adam Siepel; W Lee Kraus
Journal:  Mol Cell       Date:  2013-03-21       Impact factor: 17.970

10.  Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements.

Authors:  Christopher E Mason; Feng-Jue Shu; Cheng Wang; Ryan M Session; Roland G Kallen; Neil Sidell; Tianwei Yu; Mei Hui Liu; Edwin Cheung; Caleb B Kallen
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.